Shares of UltraTech Cement Ltd. fell on Friday despite the third quarter numbers being slightly ahead of expectations.

SoftBank and OpenAI are the lead partners for Stargate, with SoftBank having financial responsibility and OpenAI having ...

Dr. Reddy's Laboratories Ltd.'s profit rose 2% in the third quarter of the current financial year, but missed analysts' ...

Syngene International's consolidated net profit rose 18% in the third quarter of the current financial year, missing analysts ...

Revlimid is a medicine used to treat certain cancers and serious conditions affecting blood cells and bone marrow.

Zee Entertainment Enterprises Ltd. has counter claimed $8.06 million plus interest from Star India Pvt. Ltd. in a broadcasting rights dispute for International Cricket Council’s men’s tournaments over ...

Brokerages have reacted to the third-quarter financial results of UltraTech Cement Ltd., Dr. Reddy's Ltd. and Hindustan Petroleum Corporation Ltd. UltraTech remains a strong pick due to its solid ...

Amid a growing national debate on work-life balance sparked by recent comments from industry leaders, Adar Poonawalla, chief executive officer of Serum Institute of India, has emphasised the ...

The GIFT Nifty, an early indicator of the Nifty 50’s performance in India, was up 16 or 0.07% at 23,309.5 as of 7:50 a.m.

Japan’s central bank came under fire for its communication when its July rate hike helped set off a historic plunge in the country’s stocks and fueled global market turmoil. This time around, Governor ...

Syngene International revised its revenue expectations due to further delays in the US biotech funding environment during the third quarter.

Religare shares closed at Rs 253 on NSE on Jan. 22, 2025, which places the offer price at a discount of 7%, according to an exchange filing.